A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two
different doses of LY2127399 administered in participants with active SLE.